trans-3-Benzamido-1-methyl-cyclohexan | 32222-39-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: trans-3-Benzamido-1-methyl-cyclohexan
• 英文别名: (1R)-trans-3-benzamino-1-methyl-cyclohexane；(1R)-trans-3-Benzamino-1-methyl-cyclohexan；N-[(1R,3R)-3-methylcyclohexyl]benzamide
• CAS: 32222-39-2；92499-45-1
• 化学式: C₁₄H₁₉NO
• 分子量: 217.311
• InChiKey: BSTHPONDLDGVEB-DGCLKSJQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  trans-3-methylcyclohexylamine 、 苯甲酰氯 生成 trans-3-Benzamido-1-methyl-cyclohexan
  参考文献：
  名称：

  Mousseron; Canet, Bulletin de la Societe Chimique de France, 1952, p. 190,195

  摘要：

  DOI：

文献信息

• Mousseron; Canet, Bulletin de la Societe Chimique de France, 1952, p. 190,195
  作者：Mousseron、Canet

  DOI：——

  日期：——
• Reliability of the time trade-off technique of utility assessment in patients with retinal disease
  作者：Hussein Hollands、Miu Lam、Joe Pater、Dave Albiani、Gary C. Brown、Melissa Brown、Alan F. Cruess、Sanjay Sharma

  DOI：10.1016/s0008-4182(01)80041-7

  日期：2001.6

  Background: Studies in medical fields other than ophthalmology have given conflicting results regarding the reliability of the time trade-off technique of utility assessment. We performed a study to determine the test-retest reliability of the time trade-off technique for assessing utilities in patients with ocular diseases of the retina and to investigate possible factors associated with differences in utility over time.Methods: Patients referred to the retina service of a tertiary care hospital in eastern Canada were eligible for the initial interview if they had best corrected vision of 20/30 or worse in at least one eye and were deemed competent to answer the required questions. Patients were interviewed prospectively between December 1999 and March 2000 during a normal 30-minute period needed for pharmacologic mydriasis to occur. Demographic, clinical (including Snellen visual acuity) and time trade-off utility information was collected through chart review and standardized interview. Patients who completed the interview successfully were called back 28 days later for follow-up.Results: Of the 138 eligible patients 112 (81.2%) completed the initial interview. Of the 112, 96 (85.7%) completed the second interview. Half of the respondents were women, and all but one respondent were white. The mean age was 65.3 years. The primary reasons for visual loss included diabetic retinopathy (59 patients [61.4%]) and age-related macular degeneration (14 patients [14.6%]). The intraclass correlation coefficient between the initial and follow-up visual utilities was 0.7634 (95% confidence interval 0.6655-0.8355).Interpretation: Our results show excellent reliability of the time trade-off technique of utility assessment in patients with ocular diseases of the retina.